Finanzjournalistin
// by Nina Trentmann
Bisher waren es westliche Pharmakonzerne, die in China Fuß fassen wollten. Jetzt schickt sich erstmals ein chinesisches Pharmaunternehmen an, erfolgreich ins Ausland zu expandieren: Chi-Med will schon im kommenden Jahr eine Zulassung in den USA beantragen. Ich habe mir von CEO Christian Hogg in Shanghai erklären lassen, warum Chinas Arzneimittelhersteller international wachsen wollen.
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
